Unknown

Dataset Information

0

Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.


ABSTRACT:

Background and aims

Oral drug delivery is the most attractive pathway for ulcerative colitis [UC] therapy, since it has many advantages. However, this strategy has encountered many challenges, including the instability of drugs in the gastrointestinal tract [GT], low targeting of disease tissues, and severe adverse effects. Nanoparticles capable of colitis tissue-targeted delivery and site-specific drug release may offer a unique and therapeutically effective system that addresses these formidable challenges.

Methods

We used a versatile single-step surface-functionalising technique to prepare PLGA/PLA-PEG-FA nanoparticles loaded with the ginger active compound, 6-shogaol [NPs-PEG-FA/6-shogaol]. The therapeutic efficacy of NPs-PEG-FA/6-shogaol was evaluated in the well-established mouse model of dextran sulphate sodium [DSS]-induced colitis.

Results

NPs-PEG-FA exhibited very good biocompatibility both in vitro and in vivo. Subsequent cellular uptake experiments demonstrated that NPs-PEG-FA could undergo efficient receptor-mediated uptake by colon-26 cells and activated Raw 264.7 macrophage cells. In vivo, oral administration of NPs-PEG-FA/6-shogaol encapsulated in a hydrogel system [chitosan/alginate] significantly alleviated colitis symptoms and accelerated colitis wound repair in DSS-treated mice by regulating the expression levels of pro-inflammatory [TNF-?, IL-6, IL-1?, and iNOS] and anti-inflammatory [Nrf-2 and HO-1] factors.

Conclusions

Our study demonstrates a convenient, orally administered 6-shogaol drug delivery system that effectively targets colitis tissue, alleviates colitis symptoms, and accelerates colitis wound repair. This system may represent a promising therapeutic approach for treating inflammatory bowel disease [IBD].

SUBMITTER: Zhang M 

PROVIDER: S-EPMC5881712 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.

Zhang Mingzhen M   Xu Changlong C   Liu Dandan D   Han Moon Kwon MK   Wang Lixin L   Merlin Didier D  

Journal of Crohn's & colitis 20180101 2


<h4>Background and aims</h4>Oral drug delivery is the most attractive pathway for ulcerative colitis [UC] therapy, since it has many advantages. However, this strategy has encountered many challenges, including the instability of drugs in the gastrointestinal tract [GT], low targeting of disease tissues, and severe adverse effects. Nanoparticles capable of colitis tissue-targeted delivery and site-specific drug release may offer a unique and therapeutically effective system that addresses these  ...[more]

Similar Datasets

2014-04-23 | GSE57006 | GEO
| S-EPMC8512008 | biostudies-literature
2014-04-23 | E-GEOD-57006 | biostudies-arrayexpress
| S-EPMC6555859 | biostudies-literature
| S-EPMC7242005 | biostudies-literature
| S-EPMC8935238 | biostudies-literature
| S-EPMC5827822 | biostudies-other
| S-EPMC4003157 | biostudies-other
| S-EPMC9280391 | biostudies-literature
| S-EPMC6305528 | biostudies-other